Nanoparticle formulated vaccines: opportunities and challenges.

Vaccines harness the inherent properties of the immune system to prevent diseases or treat existing ones. Continuous efforts have been devoted to both gaining a mechanistic understanding of how the immune system operates and designing vaccines with high efficacies and effectiveness. Advancements in nanotechnology in recent years have generated unique opportunities to meet the daunting challenges associated with immunology and vaccine development. Firstly, nanoparticle formulated systems provide ideal model systems for studying the operation of the immune system, making it possible to systematically identify key factors and understand their roles in specific immune responses. Also, the versatile compositions/architectures of nanoparticle systems enable new strategies/novel platforms for developing vaccines with high efficacies and effectiveness. In this review, we discuss the advantages of nanoparticles and the challenges faced during vaccine development, through the framework of the immunological mechanisms of vaccination, with the aim of bridging the gap between immunology and materials science, which are both involved in vaccine design. The knowledge obtained provides general guidelines for future vaccine development.

[1]  S. Akira,et al.  SnapShot: Pattern-Recognition Receptors , 2007, Cell.

[2]  R. Langer,et al.  mRNA vaccine delivery using lipid nanoparticles. , 2016, Therapeutic delivery.

[3]  P. Savage,et al.  Natural killer T (NKT)–B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides , 2013, Proceedings of the National Academy of Sciences.

[4]  T. Schumacher,et al.  Neoantigens in cancer immunotherapy , 2015, Science.

[5]  R. Langer,et al.  Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.

[6]  R. Nahta,et al.  Herceptin: mechanisms of action and resistance. , 2006, Cancer letters.

[7]  T. Kurosaki,et al.  Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses , 2012, Proceedings of the National Academy of Sciences.

[8]  S. Plotkin.  Correlates of Protection Induced by Vaccination , 2010, Clinical and Vaccine Immunology.

[9]  J. Rosenecker,et al.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice , 2011, Nature Biotechnology.

[10]  M. Huse.  Mechanical forces in the immune system , 2017, Nature Reviews Immunology.

[11]  F. Re,et al.  Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP31 , 2008, The Journal of Immunology.

[12]  M. Wauben,et al.  Artificial antigen-presenting cells as a tool to exploit the immune `synapse' , 2000, Nature Medicine.

[13]  Wenbin Lin,et al.  Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy. , 2018, Angewandte Chemie.

[14]  Lieping Chen,et al.  Molecular mechanisms of T cell co-stimulation and co-inhibition , 2013, Nature Reviews Immunology.

[15]  Ulrich Kubitscheck,et al.  Fusogenic Liposomes as Nanocarriers for the Delivery of Intracellular Proteins. , 2017, Langmuir : the ACS journal of surfaces and colloids.

[16]  Robert L. Tanguay,et al.  Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices. , 2017, Nature nanotechnology.

[17]  Michel Sadelain,et al.  Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells , 2000, Nature Biotechnology.

[18]  Gang Bao,et al.  The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. , 2016, Nanomedicine.

[19]  C. June,et al.  Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  Robert Langer,et al.  Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation , 2019, Nature Biotechnology.

[21]  S. Rosenberg.  IL-2: The First Effective Immunotherapy for Human Cancer , 2014, The Journal of Immunology.

[22]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Darrell J Irvine,et al.  Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers , 2019, Science.

[24]  J. Whittle,et al.  Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies , 2013, Nature.

[25]  Yingying Zhang,et al.  Plasma membrane changes during programmed cell deaths , 2017, Cell Research.

[26]  R. Ransohoff,et al.  Re-establishing immunological self-tolerance in autoimmune disease , 2012, Nature Medicine.

[27]  Martin F. Bachmann,et al.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.

[28]  Özlem Türeci,et al.  Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy , 2016, Nature.

[29]  M. Yuseff,et al.  How B cells capture, process and present antigens: a crucial role for cell polarity , 2013, Nature Reviews Immunology.

[30]  K. Selmaj,et al.  Transdermal application of myelin peptides in multiple sclerosis treatment. , 2013, JAMA neurology.

[31]  T. Strutt,et al.  Expanding roles for CD4+ T cells in immunity to viruses , 2012, Nature Reviews Immunology.

[32]  Francesca Granucci,et al.  Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures , 1997, The Journal of experimental medicine.

[33]  Sai T Reddy,et al.  In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Zhijian J. Chen,et al.  A STING-Activating Nanovaccine for Cancer Immunotherapy , 2017, Nature nanotechnology.

[35]  R. Zinkernagel,et al.  Neutralizing antiviral B cell responses. , 1997, Annual review of immunology.

[36]  Ayesha Ahmad,et al.  Three-dimensional imaging of lipid gene-carriers: membrane charge density controls universal transfection behavior in lamellar cationic liposome-DNA complexes. , 2003, Biophysical journal.

[37]  T. Yokosuka,et al.  Dynamic regulation of T cell activation and co‐stimulation through TCR‐microclusters , 2010, FEBS letters.

[38]  C. Kurts,et al.  Cross-priming in health and disease , 2010, Nature Reviews Immunology.

[39]  P. Roche,et al.  The ins and outs of MHC class II-mediated antigen processing and presentation , 2015, Nature Reviews Immunology.

[40]  T. Olsson,et al.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis , 2017, Nature Reviews Neurology.

[41]  C. Kurts,et al.  Dendritic cell-targeted vaccines — hope or hype? , 2014, Nature Reviews Immunology.

[42]  R. Förster,et al.  Dendritic cell migration in health and disease , 2016, Nature Reviews Immunology.

[43]  Melanie Wilson,et al.  Immunoglobulin D enhances immune surveillance by activating antimicrobial, pro-inflammatory and B cell-stimulating programs in basophils , 2009, Nature Immunology.

[44]  J. Moon,et al.  Designer vaccine nanodiscs for personalized cancer immunotherapy , 2016, Nature materials.

[45]  D. Irvine,et al.  In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. , 2011, Molecular pharmaceutics.

[46]  S. Rosenberg,et al.  Adoptive cell transfer as personalized immunotherapy for human cancer , 2015, Science.

[47]  Wei R. Chen,et al.  NIR‐Triggered Phototherapy and Immunotherapy via an Antigen‐Capturing Nanoplatform for Metastatic Cancer Treatment , 2019, Advanced science.

[48]  A. Khoruts,et al.  Generation of Anergic and Potentially Immunoregulatory CD25+CD4 T Cells In Vivo After Induction of Peripheral Tolerance with Intravenous or Oral Antigen1 , 2001, The Journal of Immunology.

[49]  Hamidreza Ghandehari,et al.  Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[50]  R. Steinman,et al.  Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.

[51]  Amir Houshang Bahrami,et al.  Orientational changes and impaired internalization of ellipsoidal nanoparticles by vesicle membranes , 2013 .

[52]  Thomas A. Wynn,et al.  Macrophage biology in development, homeostasis and disease , 2013, Nature.

[53]  D. Peer,et al.  Next-Generation Lipids in RNA Interference Therapeutics. , 2017, ACS nano.

[54]  A. Moore,et al.  Expanding antigen-specific regulatory networks to treat autoimmunity , 2016, Nature.

[55]  Jangwook P. Jung,et al.  A self-assembling peptide acting as an immune adjuvant , 2009, Proceedings of the National Academy of Sciences.

[56]  E. Unanue,et al.  Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation , 2009, Proceedings of the National Academy of Sciences.

[57]  Tao Gong,et al.  Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[58]  J. Hubbell,et al.  Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination , 2011, Proceedings of the National Academy of Sciences.

[59]  Mark M Davis,et al.  TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation , 2010, Nature Immunology.

[60]  F. Quintana,et al.  Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2 , 2016, Science Signaling.

[61]  Yang Yang,et al.  Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity. , 2018, ACS nano.

[62]  James McCluskey,et al.  More than one reason to rethink the use of peptides in vaccine design , 2007, Nature Reviews Drug Discovery.

[63]  P. Casali,et al.  Immunoglobulin class-switch DNA recombination: induction, targeting and beyond , 2012, Nature Reviews Immunology.

[64]  Y. Lim,et al.  Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response , 2016, International journal of nanomedicine.

[65]  D. Wraith,et al.  Peptide-based therapeutic vaccines for allergic and autoimmune diseases , 2005, Nature Medicine.

[66]  J. Schneck,et al.  Linking form to function: Biophysical aspects of artificial antigen presenting cell design. , 2015, Biochimica et biophysica acta.

[67]  A. Gehring,et al.  Host–pathogen interactions in chronic HBV infection and transplantation of HCV-positive organs , 2019, Nature reviews: Gastroenterology & hepatology.

[68]  Eva K. Lee,et al.  Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans , 2009, Nature Immunology.

[69]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[70]  T. Lawrence,et al.  Homeostatic NF-κB Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and Tolerance. , 2015, Immunity.

[71]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[72]  D. Irvine,et al.  Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction , 2012, Proceedings of the National Academy of Sciences.

[73]  S. Dow,et al.  Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes1 , 2006, The Journal of Immunology.

[74]  J. Borghans,et al.  The full spectrum of human naive T cells , 2018, Nature Reviews Immunology.

[75]  M. Bevan.  Understand memory, design better vaccines , 2011, Nature Immunology.

[76]  D. Crommelin,et al.  Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. , 1997, Biochimica et biophysica acta.

[77]  Sven Frokjaer,et al.  Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. , 2005, International journal of pharmaceutics.

[78]  J. Atkinson,et al.  T-cell regulation: with complements from innate immunity , 2007, Nature Reviews Immunology.

[79]  Morteza Mahmoudi,et al.  Cellular identity of nanoparticles and the effect of the microenvironment , 2017 .

[80]  Laurence Tetley,et al.  Vesicle Size Influences the Trafficking, Processing, and Presentation of Antigens in Lipid Vesicles1 , 2004, The Journal of Immunology.

[81]  Heinz Wiendl,et al.  The role of regulatory T cells in multiple sclerosis , 2008, Nature Clinical Practice Neurology.

[82]  Karen J. Kieser,et al.  Multi-receptor detection of individual bacterial products by the innate immune system , 2017, Nature Reviews Immunology.

[83]  B. Reizis,et al.  The role of dendritic cells in autoimmunity , 2013, Nature Reviews Immunology.

[84]  Pedro M. P. Gois,et al.  Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators , 2019, Nature Nanotechnology.

[85]  Dan Peer,et al.  Toxicity profiling of several common RNAi-based nanomedicines: a comparative study , 2013, Drug Delivery and Translational Research.

[86]  J. Neefjes,et al.  Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.

[87]  Khalid A. Hajj,et al.  Tools for translation: non-viral materials for therapeutic mRNA delivery , 2017 .

[88]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[89]  K. Ewert,et al.  Cationic liposome–DNA complexes: from liquid crystal science to gene delivery applications , 2006, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[90]  K. Pienta,et al.  The Lethal Phenotype of Cancer: The Molecular Basis of Death Due to Malignancy , 2007, CA: a cancer journal for clinicians.

[91]  O. Farokhzad,et al.  Challenges in DNA Delivery and Recent Advances in Multifunctional Polymeric DNA Delivery Systems. , 2017, Biomacromolecules.

[92]  Azlan Abdul Aziz,et al.  Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles , 2018, Nanoscale Research Letters.

[93]  Darrell J Irvine,et al.  Engineering synthetic vaccines using cues from natural immunity. , 2013, Nature materials.

[94]  I. Kwon,et al.  Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy , 2017 .

[95]  Maxim Shevtsov,et al.  Nanoparticle Vaccines Against Infectious Diseases , 2018, Front. Immunol..

[96]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[97]  D. Mooney,et al.  Biomaterial-assisted targeted modulation of immune cells in cancer treatment , 2018, Nature Materials.

[98]  P. Golstein,et al.  An early history of T cell-mediated cytotoxicity , 2018, Nature Reviews Immunology.

[99]  R. Kane,et al.  Bionanotechnology for vaccine design. , 2018, Current opinion in biotechnology.

[100]  R. Landmann,et al.  A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice. , 2014, Nature chemical biology.

[101]  D. Underhill,et al.  Information processing during phagocytosis , 2012, Nature Reviews Immunology.

[102]  O. Joffre,et al.  Cross-presentation by dendritic cells , 2012, Nature Reviews Immunology.

[103]  N. Cools,et al.  Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis , 2018, CNS Drugs.

[104]  Rino Rappuoli,et al.  From empiricism to rational design: a personal perspective of the evolution of vaccine development , 2014, Nature Reviews Immunology.

[105]  Daejin Kim,et al.  Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo. , 2012, Angewandte Chemie.

[106]  F. Batista,et al.  The who, how and where of antigen presentation to B cells , 2009, Nature Reviews Immunology.

[107]  R. Schreiber,et al.  Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.

[108]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[109]  P. Sharma,et al.  The future of immune checkpoint therapy , 2015, Science.

[110]  Graham M Lord,et al.  T-bet: a bridge between innate and adaptive immunity , 2013, Nature Reviews Immunology.

[111]  John Steel,et al.  Programming the magnitude and persistence of antibody responses with innate immunity , 2010, Nature.

[112]  Jonathan P Schneck,et al.  Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells. , 2014, Biomaterials.

[113]  Michael J Sailor,et al.  Immunogene therapy with fusogenic nanoparticles modulates macrophage response to Staphylococcus aureus , 2018, Nature Communications.

[114]  A. Iwasaki.  Antiviral immune responses in the genital tract: clues for vaccines , 2010, Nature Reviews Immunology.

[115]  S. Gabrielsson,et al.  Adjuvant properties of mesoporous silica particles tune the development of effector T cells. , 2012, Small.

[116]  I. Verma,et al.  Cationic liposome-mediated RNA transfection. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Wah Chiu,et al.  Interbilayer-Crosslinked Multilamellar Vesicles as Synthetic Vaccines for Potent Humoral and Cellular Immune Responses , 2011, Nature materials.

[118]  J. Behr,et al.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[119]  V. Kuchroo,et al.  High Frequency of Autoreactive Myelin Proteolipid Protein–Specific T Cells in the Periphery of Naive Mice , 2000, The Journal of experimental medicine.

[120]  Yuliang Zhao,et al.  Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing. , 2019, ACS applied materials & interfaces.

[121]  Tian Zhang,et al.  Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy , 2017, Nature Nanotechnology.

[122]  M. Soares,et al.  Disease tolerance and immunity in host protection against infection , 2017, Nature Reviews Immunology.

[123]  Zhuang Liu,et al.  Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy. , 2019, Biomaterials.

[124]  Young Keun Kim,et al.  A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. , 2011, Nature nanotechnology.

[125]  P. Cullis,et al.  Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. , 2001, Biochimica et biophysica acta.

[126]  T. Wan,et al.  Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination. , 2018, Nature materials.

[127]  A. Iwasaki,et al.  Early local immune defences in the respiratory tract , 2016, Nature Reviews Immunology.

[128]  Yuan Cheng,et al.  Iron Oxide Nanoparticles-Based Vaccine Delivery for Cancer Treatment. , 2018, Molecular pharmaceutics.

[129]  Markus G. Manz,et al.  Development of Monocytes, Macrophages, and Dendritic Cells , 2010, Science.

[130]  Özlem Türeci,et al.  mRNA-based therapeutics — developing a new class of drugs , 2014, Nature Reviews Drug Discovery.

[131]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[132]  D. Weissman,et al.  mRNA vaccines — a new era in vaccinology , 2018, Nature Reviews Drug Discovery.

[133]  S. Amigorena,et al.  Fcγ Receptors and Cross-Presentation in Dendritic Cells , 2002, The Journal of experimental medicine.

[134]  Roberto A. Maldonado,et al.  Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance , 2014, Proceedings of the National Academy of Sciences.

[135]  J. Vávra,et al.  Anchored but not internalized: shape dependent endocytosis of nanodiamond , 2017, Scientific Reports.

[136]  J. Trapani,et al.  Endolysosomal proteases and their inhibitors in immunity , 2009, Nature Reviews Immunology.

[137]  J. Hubbell,et al.  Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose , 2013, Proceedings of the National Academy of Sciences.

[138]  I. Gursel,et al.  CpG ODN Nanorings Induce IFNα from Plasmacytoid Dendritic Cells and Demonstrate Potent Vaccine Adjuvant Activity , 2014, Science Translational Medicine.

[139]  Takafumi Ninomiya,et al.  Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. , 2013, ACS nano.

[140]  Douglas M. Smith,et al.  Applications of nanotechnology for immunology , 2013, Nature Reviews Immunology.

[141]  Chih-Kuang Chen,et al.  Overcoming nonviral gene delivery barriers: perspective and future. , 2013, Molecular pharmaceutics.

[142]  Takashi Saito,et al.  Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76 , 2005, Nature Immunology.

[143]  Samir Mitragotri,et al.  Polymer particle shape independently influences binding and internalization by macrophages. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[144]  Wantong Song,et al.  Nanomaterials for cancer immunotherapy. , 2017, Biomaterials.

[145]  L. Zitvogel,et al.  Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway , 2010, Clinical Cancer Research.

[146]  U. Şahin,et al.  Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. , 2006, Blood.

[147]  Mei X. Wu,et al.  Physical activation of innate immunity by spiky particles , 2018, Nature Nanotechnology.

[148]  Daniel G. Anderson,et al.  Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs. , 2015, Nano letters.

[149]  R. Drezek,et al.  In vivo gold nanoparticle delivery of peptide vaccine induces anti-tumor immune response in prophylactic and therapeutic tumor models. , 2015, Small.

[150]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[151]  Bali Pulendran,et al.  Immunological mechanisms of vaccination , 2011, Nature Immunology.

[152]  L. Lanier,et al.  Natural killer cell memory in infection, inflammation and cancer , 2016, Nature Reviews Immunology.

[153]  Sai T Reddy,et al.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.

[154]  S. Hacein-Bey-Abina,et al.  Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand? , 2016, Human gene therapy.

[155]  M. Carroll,et al.  Follicular dendritic cells: dynamic antigen libraries , 2014, Nature Reviews Immunology.

[156]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[157]  G. Ma,et al.  pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response. , 2015, ACS nano.

[158]  Shimon Sakaguchi,et al.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity , 2010, Nature Immunology.

[159]  A. Jones,et al.  Nanoparticle geometry and surface orientation influence mode of cellular uptake. , 2013, ACS nano.

[160]  F. Szoka,et al.  Lipid-based Nanoparticles for Nucleic Acid Delivery , 2007, Pharmaceutical Research.

[161]  Qinjian Zhao,et al.  Calcium phosphate nanoparticles as a new generation vaccine adjuvant , 2017, Expert review of vaccines.

[162]  C. J. Hu,et al.  Advances and Opportunities in Nanoparticle‐ and Nanomaterial‐Based Vaccines against Bacterial Infections , 2018, Advanced healthcare materials.

[163]  Reinhard Grisshammer,et al.  Understanding recombinant expression of membrane proteins. , 2006, Current opinion in biotechnology.